Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.3849
+0.0033 (0.86%)
Jun 18, 2025, 4:00 PM - Market closed

Elevation Oncology Statistics

Total Valuation

ELEV has a market cap or net worth of $22.81 million. The enterprise value is -$26.60 million.

Market Cap 22.81M
Enterprise Value -26.60M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date Aug 5, 2025
Ex-Dividend Date n/a

Share Statistics

ELEV has 59.25 million shares outstanding. The number of shares has increased by 35.68% in one year.

Current Share Class 59.25M
Shares Outstanding 59.25M
Shares Change (YoY) +35.68%
Shares Change (QoQ) +0.09%
Owned by Insiders (%) 0.36%
Owned by Institutions (%) 39.89%
Float 43.54M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.49
P/TBV Ratio 0.49
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 19.40, with a Debt / Equity ratio of 0.67.

Current Ratio 19.40
Quick Ratio 19.04
Debt / Equity 0.67
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11.80

Financial Efficiency

Return on equity (ROE) is -78.32% and return on invested capital (ROIC) is -30.93%.

Return on Equity (ROE) -78.32%
Return on Assets (ROA) -29.86%
Return on Invested Capital (ROIC) -30.93%
Return on Capital Employed (ROCE) -58.57%
Revenue Per Employee n/a
Profits Per Employee -$1.41M
Employee Count 34
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, ELEV has paid $38,000 in taxes.

Income Tax 38,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -87.06% in the last 52 weeks. The beta is 1.45, so ELEV's price volatility has been higher than the market average.

Beta (5Y) 1.45
52-Week Price Change -87.06%
50-Day Moving Average 0.34
200-Day Moving Average 0.52
Relative Strength Index (RSI) 63.35
Average Volume (20 Days) 2,015,319

Short Selling Information

The latest short interest is 2.55 million, so 4.31% of the outstanding shares have been sold short.

Short Interest 2.55M
Short Previous Month 4.43M
Short % of Shares Out 4.31%
Short % of Float 5.86%
Short Ratio (days to cover) 3.14

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -45.68M
Pretax Income -39.66M
Net Income -47.99M
EBITDA -45.66M
EBIT -45.68M
Earnings Per Share (EPS) -$0.81
Full Income Statement

Balance Sheet

The company has $80.66 million in cash and $31.25 million in debt, giving a net cash position of $49.41 million or $0.83 per share.

Cash & Cash Equivalents 80.66M
Total Debt 31.25M
Net Cash 49.41M
Net Cash Per Share $0.83
Equity (Book Value) 46.73M
Book Value Per Share 0.79
Working Capital 77.96M
Full Balance Sheet

Cash Flow

Operating Cash Flow -39.50M
Capital Expenditures n/a
Free Cash Flow -39.50M
FCF Per Share -$0.67
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ELEV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -35.68%
Shareholder Yield -35.68%
Earnings Yield -210.42%
FCF Yield -173.20%

Analyst Forecast

The average price target for ELEV is $1.77, which is 359.86% higher than the current price. The consensus rating is "Hold".

Price Target $1.77
Price Target Difference 359.86%
Analyst Consensus Hold
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1